Springworks Therapeutics Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Springworks Therapeutics Inc 's ROA in the first quarter of 2025?
Springworks Therapeutics Inc recorded a cumulative net loss of $-258 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -44.94%.

However, within the Healthcare sector Springworks Therapeutics Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the fourth quarter of 2024 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Total Assets Change	-23.29 %	-19.32 %	30.22 %	19.29 %	13.45 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-258	-258	-325	-325	-325
Return On Assets (TTM)	-44.94 %	-42.15 %	-50.23 %	-53.1 %	-55.33 %
SWTX's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	500	582	603	612	652
Seq. Total Assets Change	-14.08 %	-3.43 %	-1.45 %	-6.18 %	-9.64 %
Seq. Net Income Change	-	-	-	-	-

SWTX's 5 Years Annual ROA >> Back to SWTX Management Effectiveness >> Compare SWTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Springworks Therapeutics Inc 's Assets	$ 500 million	SWTX's Balance sheet
Springworks Therapeutics Inc 's Income	$ 0 million	Quarterly SWTX's Income Statement
SWTX's Income by Division		See SWTX's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	-19.32 %	14.92 %	38.92 %	-21.44 %	71.87 %
Total Assets in million	582	722	628	452	575
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-258	-325	-277	-174	-46
Annual Return On Assets	-44.33 %	-45.04 %	-44.17 %	-38.47 %	-7.92 %

SWTX's 5 Years Annual ROA >> Back to SWTX Management Effectiveness >> Compare SWTX ROA to its Competitors

More Return On Assets Ratios
SWTX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SWTX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SWTX's Competitors
Subscribers only: Roa for Springworks Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for SWTX's Customers

You may also want to know
SWTX's Roi	SWTX's Inventory Turnover Ratio	SWTX's Growth Rates	SWTX's Dividend Comparisons
	SWTX's Profitability Ratios	SWTX's Asset Turnover Ratio	SWTX's Dividend Growth
SWTX's Roe	SWTX's Valuation Ratios	SWTX's Financial Strength Ratios	SWTX's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector

ROA

Date modified: 2026-09-02T08:18:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.